Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Iversen

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Antisense & Nucleic Acid Drug Development|March 22, 2000
In vivo evaluation of a morpholino antisense oligomer directed against tumor necrosis factor-alphaG Qin, M Taylor, Y Y Ning, et al.
Urologia Internationalis|January 1, 1983
Significance of prostatic weight in prostatismK M Jensen, R C Bruskewitz, P Iversen, et al.
Urology|October 1, 1984
Spontaneous uroflowmetry in prostatismK M Jensen, R C Bruskewitz, P Iversen, et al.
The Journal of Urology|January 1, 1983
Abdominal straining in benign prostatic hyperplasiaK M Jensen, R C Bruskewitz, P Iversen, et al.
The Journal of Urology|May 1, 1983
Transurethral prostatic resection in the treatment of prostatism with high urinary flowP Iversen, R C Bruskewitz, K M Jensen, et al.
Urology|May 1, 1983
Modified J nephrostomy catheter for intravesical pressure measurement in urodynamicsP Iversen, K M Jensen, R C Bruskewitz, et al.
Urology|May 20, 1998
Prostate cancer in Denmark: a 50-year population-based studyK Brasso, S Friis, S K Kjaer, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1983
Comparison of concentrations of rifampin and a new rifamycin derivative, DL 473, in canine boneP Iversen, O S Nielsen, K M Jensen, et al.
Biochimie|January 1, 1993
An FPLC method for determination of calpains and calpastatin in porcine m longissimus dorsiP Iversen, P Ertbjerg, L M Larsen, et al.
European Urology|October 24, 2003
Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancerW See, P Iversen, M Wirth, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Antisense & Nucleic Acid Drug Development|March 22, 2000
In vivo evaluation of a morpholino antisense oligomer directed against tumor necrosis factor-alphaG Qin, M Taylor, Y Y Ning, et al.
Urologia Internationalis|January 1, 1983
Significance of prostatic weight in prostatismK M Jensen, R C Bruskewitz, P Iversen, et al.
Urology|October 1, 1984
Spontaneous uroflowmetry in prostatismK M Jensen, R C Bruskewitz, P Iversen, et al.
The Journal of Urology|January 1, 1983
Abdominal straining in benign prostatic hyperplasiaK M Jensen, R C Bruskewitz, P Iversen, et al.
The Journal of Urology|May 1, 1983
Transurethral prostatic resection in the treatment of prostatism with high urinary flowP Iversen, R C Bruskewitz, K M Jensen, et al.
Urology|May 1, 1983
Modified J nephrostomy catheter for intravesical pressure measurement in urodynamicsP Iversen, K M Jensen, R C Bruskewitz, et al.
Urology|May 20, 1998
Prostate cancer in Denmark: a 50-year population-based studyK Brasso, S Friis, S K Kjaer, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1983
Comparison of concentrations of rifampin and a new rifamycin derivative, DL 473, in canine boneP Iversen, O S Nielsen, K M Jensen, et al.
Biochimie|January 1, 1993
An FPLC method for determination of calpains and calpastatin in porcine m longissimus dorsiP Iversen, P Ertbjerg, L M Larsen, et al.
European Urology|October 24, 2003
Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancerW See, P Iversen, M Wirth, et al.
Pageof 15